Tango Therapeutics, Inc. (TNGX)
9.10
-0.07
(-0.76%)
USD |
NASDAQ |
Dec 11, 16:00
9.115
+0.02
(+0.16%)
Pre-Market: 20:00
Tango Therapeutics Free Cash Flow: -146.76M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| XOMA Royalty Corp. | -15.89M |
| Viking Therapeutics, Inc. | -224.58M |
| Avanos Medical, Inc. | 74.90M |
| Krystal Biotech, Inc. | 165.59M |
| Moderna, Inc. | -2.663B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -30.95M |
| Cash from Investing (Quarterly) | 47.48M |
| Cash from Financing (Quarterly) | 2.541M |
| Free Cash Flow Per Share (Quarterly) | -0.2803 |
| Free Cash Flow to Equity (Quarterly) | -30.86M |
| Free Cash Flow to Firm (Quarterly) | -31.10M |
| Free Cash Flow Yield | -14.65% |